What is Sildenafil and What is Revatio?
Sildenafil is the active ingredient in the medication Revatio, which is prescribed to treat pulmonary arterial hypertension (PAH) [1]. PAH is a condition characterized by high blood pressure in the arteries of the lungs and the right side of the heart [1]. Revatio works by relaxing and widening blood vessels in the lungs, which reduces pressure and improves blood flow [1]. Sildenafil also has other medical uses, most notably in treating erectile dysfunction under the brand name Viagra [2].
When Did Revatio Go Generic?
Revatio, containing sildenafil citrate, lost its market exclusivity and became available as a generic drug in the United States in November 2012 [3]. This followed patent expirations, allowing other pharmaceutical companies to manufacture and market their own versions of the medication [3].
What Are the Benefits of Generic Sildenafil?
Generic versions of Revatio offer the same active ingredient, sildenafil citrate, and are manufactured to meet the same safety, quality, and effectiveness standards as the brand-name drug [4]. The primary benefit of generic medications is their lower cost compared to their brand-name counterparts [4]. This can make treatment more accessible and affordable for patients managing conditions like PAH.
How Does Generic Sildenafil Compare to Brand-Name Revatio?
Generic sildenafil is therapeutically equivalent to Revatio [4]. This means that both contain the same active ingredient in the same dosage form and strength, and they are absorbed into the body at the same rate and to the same extent [4]. Therefore, patients can expect the same clinical effect from generic sildenafil as they would from Revatio.
Who Manufactures Generic Sildenafil for PAH?
Multiple pharmaceutical manufacturers produce generic versions of sildenafil for the treatment of PAH [5]. Companies like Teva Pharmaceuticals, Mylan (now Viatris), and Aurobindo Pharma are among those that have offered generic sildenafil [5]. The availability of generics can vary by region and pharmacy.
What is the Patent Situation for Sildenafil (Revatio)?
The primary patents protecting Revatio, originally held by Pfizer, have expired in major markets, including the U.S. and Europe, allowing for the introduction of generic versions [3][6]. DrugPatentWatch.com tracks patent expirations and litigation related to pharmaceuticals, including sildenafil [6]. Patent expirations are crucial for the entry of generic competition [6].
What Are the Risks and Side Effects of Sildenafil?
Like all medications, sildenafil can cause side effects [1]. Common side effects of Revatio (sildenafil) include headache, flushing, upset stomach, and changes in color vision [1]. More serious side effects can occur, and patients should consult their healthcare provider if they experience any concerning symptoms [1]. The risks and side effects are generally consistent between the brand-name and generic versions due to the identical active ingredient.
What Are the Regulatory Aspects of Generic Sildenafil?
In the United States, generic drugs are approved by the Food and Drug Administration (FDA) through the Abbreviated New Drug Application (ANDA) process [4]. The FDA ensures that generic drugs are bioequivalent to their brand-name counterparts, meaning they work the same way in the body [4]. Regulatory approval confirms that generic sildenafil meets all the required standards for safety and efficacy.
Sources:
[1] https://www.drugs.com/revatio.html
[2] https://www.drugs.com/sildenafil.html
[3] https://www.drugpatentwatch.com/drug/revatio
[4] https://www.fda.gov/drugs/generic-drugs
[5] https://www.goodrx.com/sildenafil
[6] https://www.drugpatentwatch.com/